Nevirapine

Product NDC: 65862-027
11-digit product format: 658620027
Labeler code: 65862
Product ID: 65862-027_0f465f42-d781-453e-ac8c-f5017bf06fe1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Nevirapine
Dosage form: TABLET
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA077521
Marketing category: ANDA
Marketing start: 2012-05-22
Substance: NEVIRAPINE
Active strength: 200 mg/1
Pharmacologic classes: Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
unfinished product	product	65862-027		UNFINISHED	Active or certified unfinished drug listing	2026-10-12
unfinished package	package	65862-027	65862-027-15	UNFINISHED	Active or certified unfinished drug listing	2026-10-12
unfinished package	package	65862-027	65862-027-38	UNFINISHED	Active or certified unfinished drug listing	2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 61 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-027-38	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-027-15	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-027-38	`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-027-15	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-027-38	`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-027-15	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-027-38	`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-027-15	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-027-38	`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-027-15	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-027-38	`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-027-15	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-027-38	`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-027-15	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-027-38	`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-027-15	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-027-38	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-027-15	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-027-38	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-027-15	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-027-38	`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-027-15	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-027-38	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-027-15	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-027-38	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-027-15	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-027-38	`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-027-15	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-027-15	`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-027-38	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-027-15	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-027-38	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-027-15	`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-027-38	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-027-15	`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-027-38	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-027-15	`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-027-38	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-027-38	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077521-001	NEVIRAPINE	NEVIRAPINE	200MG	TABLET / ORAL	AB		2012-05-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A077521-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077521-001	NEVIRAPINE	200MG	TABLET / ORAL	AB	2012-05-22	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-09-29 23:25 UTC	2022-09	A077521-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077521-001	AB	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077521-001	AB	1	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Nevirapine
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NEVIRAPINE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
99DK7FVK1H	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199422	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5f6c3eed-2a5d-46ed-9a7c-59715f338a15	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a1bab0e5-3c0a-775a-2f29-a19e4e281871	Product name	3	20190610
d07e0b9e-e041-41dc-942a-a2a6601dc221	Product name	1	20181029
0d48f664-b8cd-5c4b-aa8e-0a00f1c0002d	Product name	8	20171204

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-027-10	Nevirapine	10 in 1 BLISTER PACK	TABLET	10	9
65862-027-10	Nevirapine	6 in 1 CARTON	TABLET	6	9
65862-027-60	Nevirapine	60 in 1 BOTTLE	TABLET	60	9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-027-60	EA - Each	65862-027	6b273486-ec5c-4a17-b0d9-758e01ae7233	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NEVIRAPINE	ACTIVE INGREDIENT	99DK7FVK1H	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
NEVIRAPINE	ACTIVE MOIETY	99DK7FVK1H	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-027	NEVIRAPINE TABLET [AUROBINDO PHARMA LIMITED]	9	Current NDC, Legacy NDC, 3 package rows	20240521_5f6c3eed-2a5d-46ed-9a7c-59715f338a15.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nevirapine	NEVIRAPINE	Aurobindo Pharma Limited	5f6c3eed-2a5d-46ed-9a7c-59715f338a15	2024-05-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077521 application number: ANDA077521 ndc (product): 65862-027

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
99DK7FVK1H	NEVIRAPINE	129618-40-2	NEVIRAPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199422	nevirapine 200 MG Oral Tablet	PSN	5f6c3eed-2a5d-46ed-9a7c-59715f338a15	9
199422	nevirapine 200 MG Oral Tablet	SCD	5f6c3eed-2a5d-46ed-9a7c-59715f338a15	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-027-10	65862002710	6 BLISTER PACK in 1 CARTON (65862-027-10) / 10 TABLET in 1 BLISTER PACK	6 blister pack	2012-05-22	0000-00-00	No	No	Current
65862-027-15	65862002715	1500 TABLET in 1 BAG (65862-027-15)	1500 tablet	27-DEC-19				Current
65862-027-38	65862002738	1800 TABLET in 1 BAG (65862-027-38)	1800 tablet	22-MAY-12				Current
65862-027-60	65862002760	60 TABLET in 1 BOTTLE (65862-027-60)	60 tablet	2012-05-22	0000-00-00	No	No	Current